Anteris Technologies Global logo
Anteris Technologies Global
AVR | NASDAQ
Chart Builder DCF Calculator
$5.70
+$0.28 (+5.17%)
At close: Nov 16, 2026, 4:00 PM ET
$5.68
-$0.02 (-0.35%)
After-hours: Nov 16, 2026, 6:33 PM ET

Anteris Technologies Global Company Profile

Company profile explained

Company Profile

Anteris Technologies Global Corp. is a structural heart innovator dedicated to discovering, developing, and bringing to market medical devices that enhance the well-being of patients grappling with aortic stenosis. The company's premier offering is the DurAVR transcatheter heart valve system, a pioneering transcatheter aortic valve engineered to treat aortic stenosis by precisely emulating the performance of a healthy human aortic valve. Beyond this, Anteris develops ADAPT anti-calcification tissue, a unique preparation that transforms xenograft tissue into robust bioscaffolds. These bioscaffolds are designed to simulate human tissue for various surgical repairs, notably in aortic valve replacement. Additionally, the ComASUR delivery system, a physician-designed balloon-expandable apparatus, features a reinforced, steerable catheter. This allows for highly accurate navigation through cardiac anatomy in a controlled manner, thereby mitigating potential damage to the aorta. Founded in 1999, Anteris Technologies Global Corp. operates out of Toowong, Australia.

Key Executives

Name Position
Wayne Geoffrey Paterson Vice Chairman & Chief Executive Officer
Brent A. Moen Chief Financial Officer
Chris Meduri Chief Medical Officer & Member of Medical Advisory Board
David Denis President & Director
Matthew McDonnell Head of Australia

Latest SEC Filings

Date Type Title
Oct 28, 2026 PRE 14A Filing
Oct 08, 2026 4 Filing
Oct 06, 2026 4 Filing
Oct 01, 2026 4 Filing
Sep 24, 2026 424B3 Filing
Sep 23, 2026 8-K Current Report
Sep 21, 2026 424B3 Filing
Sep 17, 2026 8-K Current Report
Sep 16, 2026 4 Filing
Sep 16, 2026 3 Filing
View All SEC Filings ➞
Anteris Technologies Global
Anteris Technologies Global logo
Country United States
IPO Date Dec 13, 2024
Industry Medical - Devices
Sector Healthcare
Employees 174
CEO Wayne Geoffrey Paterson

Contact Details

860 Blue Gentian Road, Suite 340 Eagan, Minnesota 55121 United States

Stock Details

Ticker Symbol AVR
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0002011514
CUSIP Number 03675P102
ISIN Number US03675P1021
SIC Code 3842

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.